Neurogene (NGNE) Non Operating Income (2013 - 2026)
Neurogene (NGNE) recorded Non Operating Income of $2.18 million in Q2 2026, down 46.3% from $4.07 million a year earlier and down 9.6% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Non Operating Income (2013 - 2026) Analysis & Trends
On a TTM basis, Neurogene's Non Operating Income came in at $10.24 million as of Jun 30, 2026, down 9.4% year-over-year; for FY2025, it came in at $12.98 million, up 73.9% from FY2024.
- Annual Non Operating Income has a five-year compound annual growth rate of 95.8% (FY2020 to FY2025).
- Across earlier years, Non Operating Income came in at $7.46 million in FY2024 (-61.3%), $19.27 million in FY2023, -$42,000 in FY2022 and -$13,000 in FY2021.
- The Q2 2026 figure is the lowest quarterly Non Operating Income since Q4 2024.
- On a year-over-year basis, Non Operating Income rose in four of the last seven quarters, with growth averaging 20.9%.
- Per Business Quant, the preceding three quarters came in at $2.42 million (Q1 2026), $2.79 million (Q4 2025) and $2.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Neurogene | 627.40 Mn | 627.40 Mn | - | 2.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.18 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Dec 31, 2025 | 2.79 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 19.28 Mn |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2022 | -22,000.00 |
| Jun 30, 2022 | -11,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Jun 30, 2021 | -5,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -2,000.00 |
API Access
Neurogene Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();